Trial intelligence / Profile preview

Progenitor Biological Bandages in Burn Care

NCT05339490Phase 2Terminated

Start
Jul 2025
Primary completion
Jul 2025
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of selected CD133+ cells in burn injury, donor site wound. Started Jul 2025; status: terminated.

02

Drugs

selected CD133+ cells
03

Conditions

burn injurydonor site wound

Beyond the preview

Go deeper on NCT05339490.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05339490.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call